Search Results - "Grivcheva Panovska, Vesna"
-
1
Body dysmorphia in common skin diseases: results of an observational, cross‐sectional multicentre study among dermatological outpatients in 17 European countries
Published in British journal of dermatology (1951) (01-07-2022)“…Summary Background Body dysmorphic disorder (BDD) is a common psychiatric disorder associated with high costs for healthcare systems as patients may repeatedly…”
Get full text
Journal Article -
2
Recombinant human C1 esterase inhibitor treatment for hereditary angioedema attacks in children
Published in Pediatric allergy and immunology (01-08-2019)“…Background Attacks of hereditary angioedema (HAE) due to C1 esterase inhibitor deficiency (C1‐INH‐HAE) usually begin during childhood or adolescence. However,…”
Get full text
Journal Article -
3
Management of Hereditary Angioedema in North Macedonia compared to regional and Western European data
Published in The World Allergy Organization journal (01-08-2020)Get full text
Journal Article -
4
Population pharmacokinetics of plasma-derived C1 esterase inhibitor concentrate used to treat acute hereditary angioedema attacks
Published in Annals of allergy, asthma, & immunology (01-08-2010)“…Background C1 esterase inhibitor (C1-INH) replacement is recommended as a first-line therapy for acute edema attacks in hereditary angioedema (HAE). Only…”
Get full text
Journal Article -
5
Efficacy of human C1 esterase inhibitor concentrate compared with placebo in acute hereditary angioedema attacks
Published in Journal of allergy and clinical immunology (01-10-2009)“…Background Hereditary angioedema caused by C1 esterase inhibitor deficiency is a rare disorder. Objective To compare the efficacy of pasteurized C1 esterase…”
Get full text
Journal Article -
6
Perceived Stigmatization among Dermatological Outpatients Compared with Controls: An Observational Multicentre Study in 17 European Countries
Published in Acta dermato-venereologica (22-06-2023)“…Perceived stigmatization places a large psychosocial burden on patients with some skin conditions. Little is known about the experience of stigmatization…”
Get full text
Journal Article -
7
Oral Sebetralstat for On-Demand Treatment of Hereditary Angioedema Attacks
Published in The New England journal of medicine (04-07-2024)“…In this trial involving 264 hereditary angioedema attacks, oral sebetralstat provided faster times to the beginning of symptom relief, reduction in attack…”
Get full text
Journal Article -
8
Stigmatization and perceived health status in patients with hidradenitis suppurativa: an observational multicenter study in Europe
Published in International journal of dermatology (11-11-2024)“…Abstract Introduction Hidradenitis suppurativa (HS) can severely affect the quality of life (QoL) and is linked to psychological distress, including anxiety,…”
Get full text
Journal Article -
9
Mitigating Disparity in Health-care Resources Between Countries for Management of Hereditary Angioedema
Published in Clinical reviews in allergy & immunology (01-08-2021)“…Hereditary angioedema (HAE) is a rare genetic disorder characterized by recurrent episodes of skin and mucosal edema. The main treatment goal is to enable a…”
Get full text
Journal Article -
10
Long‐term safety and effectiveness of berotralstat for hereditary angioedema: The open‐label APeX‐S study
Published in Clinical and translational allergy (01-06-2021)“…Background Berotralstat (BCX7353) is an oral, once‐daily inhibitor of plasma kallikrein recently approved for prevention of angioedema attacks in adults and…”
Get full text
Journal Article -
11
Hereditary Angioedema Attack in Utero and Treatment of the Mother and Fetus
Published in Mayo Clinic proceedings. Innovations, quality & outcomes (01-10-2020)“…Hereditary angioedema (HAE), an inherited deficiency of functional C1 esterase inhibitor (C1-INH), is characterized by unpredictable recurrent episodes of…”
Get full text
Journal Article -
12
Recombinant human C1 esterase inhibitor for hereditary angioedema attacks: A European registry
Published in The World Allergy Organization journal (01-04-2021)“…Hereditary angioedema (HAE) due to C1 esterase inhibitor deficiency (C1-INH-HAE) is characterized by recurrent swelling attacks. A European treatment registry…”
Get full text
Journal Article -
13
-
14
Global perceptions of the current and future impacts of COVID-19 on hereditary angioedema management
Published in Allergy and asthma proceedings (01-01-2022)“…The coronavirus disease 2019 (COVID-19) pandemic has greatly affected health-care provision across the globe. Management of chronic ailments has become…”
Get more information
Journal Article -
15
International consensus on the diagnosis and management of pediatric patients with hereditary angioedema with C1 inhibitor deficiency
Published in Allergy (01-02-2017)“…Background The consensus documents published to date on hereditary angioedema with C1 inhibitor deficiency (C1‐INH‐HAE) have focused on adult patients. Many of…”
Get full text
Journal Article Conference Proceeding -
16
Oral Plasma Kallikrein Inhibitor for Prophylaxis in Hereditary Angioedema
Published in The New England journal of medicine (26-07-2018)“…The clinical consequences of defects in C1 inhibitor function can be serious. A series of advances have improved the outlook for patients with hereditary…”
Get full text
Journal Article -
17
Recombinant human C1 esterase inhibitor for prophylaxis of hereditary angio-oedema: a phase 2, multicentre, randomised, double-blind, placebo-controlled crossover trial
Published in The Lancet (British edition) (30-09-2017)“…Hereditary angio-oedema is a recurrent, oedematous disorder caused by deficiency of functional C1 inhibitor. Infusions of plasma-derived C1 esterase inhibitor…”
Get full text
Journal Article -
18
An investigational oral plasma kallikrein inhibitor for on-demand treatment of hereditary angioedema: a two-part, randomised, double-blind, placebo-controlled, crossover phase 2 trial
Published in The Lancet (British edition) (11-02-2023)“…Guidelines recommend effective on-demand therapy for all individuals with hereditary angioedema. We aimed to assess the novel oral plasma kallikrein inhibitor,…”
Get full text
Journal Article -
19
Hereditary Angioedema Attacks in Patients Receiving Long-Term Prophylaxis: A Systematic Review
Published in Clinical reviews in allergy & immunology (07-11-2024)“…Abstract Long-term prophylaxis (LTP) has been shown to reduce the frequency of hereditary angioedema (HAE) attacks; however, attacks occurring in patients…”
Get full text
Journal Article -
20